Repligen Corporation has acquired 908 Devices' desktop portfolio, which includes four analytical devices for bioprocessing applications, for $70 million in cash. This acquisition enhances Repligen's ...
On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. The ...
(RTTNews) - Repligen Corporation (RGEN) announced the acquisition of a desktop bioprocessing analytical technology portfolio from 908 Devices for $70 million in cash. The portfolio includes four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback